When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADMA - IBio: Slow On COVID-19 Clinical Progress A Viable Short Candidate
ADMA Biologics Inc
A recent 10-Q for IBIO mentions the word "plasma" just once.
IBIO isn't a plasma company like ADMA and isn't developing a plasma-derived product for COVID-19 like KMDA. IBIO can make proteins in plants, such as plasma proteins, so can other.
IBIO is late to the game with a recent COVID-19 therapeutic and the company is still not in trials with its COVID-19 vaccine.